#USA #Houston #AI Drug Discovery #Sino Biological #4RISE

Sino Biological Launches 4RISE™: High-Throughput Wet-Lab Services

Sino Biological, Inc., a global leader in recombinant technology, has recently announced the launch of its new high-performance wet-lab service, 4RISE™. This innovative service is designed to facilitate the validation of AI-designed protein binders, aiming to enhance the drug discovery process. With 4RISE™, researchers can validate the activity of their designed agents using rapid experimental workflows, paving the way for more efficient discoveries in biological science.

Accelerated Validation Process

The 4RISE™ service offers an incredibly fast validation process, starting with a cell-free protein synthesis using the XPressMAX™ platform. This state-of-the-art technology allows for the synthesis of recombinant proteins in just 3 hours, boasting a success rate that exceeds 99% in established workflows. All types of proteins, including miniproteins, VHHs, scFv, Fabs, enzymes, and cytokines can be rapidly created, which significantly accelerates preliminary testing of AI-designed protein candidates.

In just 3 days, researchers receive AI-ready aggregation data through the integration of high-throughput screening technologies such as the Carterra, Biacore SPR, and Octet BLI. This efficient workflow presents a streamlined approach, allowing for quick feedback and iterative design modifications for future experiments.

Flexible Workflow Solutions

The 4RISE™ service provides researchers with flexible screening and characterization workflows adapted to a variety of candidate formats and target validation needs. Among its features are:

• - Rapid Hit Discovery: Identifying positively aggregating miniproteins and VHHs through a crude supernatant screening.
• - Comparative Screening: Evaluating purified candidates under standardized conditions to prioritize selection.
• - Characterization of Affinity and Kinetics: Offering quantitative insights into aggregation for effective compound selection.
• - Specialized Binder Validation: Supporting a diverse range of formats through tailored aggregation analysis and mammalian expression methods.

Beyond aggregation, 4RISE™ also provides more than 20 development capability assays, over 1000 protein bioactivity assays, and more than 10 functional assays based on cells. This allows comprehensive candidate evaluation and optimal design functionalities.

Proven Experience in Wet-Lab Validation

Sino Biological has partnered with numerous AI companies for wet-lab validation in antibody discovery, de novo binder design, and protein computational engineering. The 4RISE™ services have been integral in supporting research published in prominent journals such as Science, Nature Communications, and Scientific Reports.

Dr. Rob Burgess, the Commercial Director of Sino Biological US, emphasized the critical need for empirical wet-lab evidence for AI-constructed molecules to confirm their potential. He stated, “Our integrated capabilities equip researchers with the high-quality data they need to rapidly evaluate candidates, shorten design cycles, and transform promising discoveries into real-world applications.”

Conclusion

For researchers and institutions engaged in drug discovery, the unveiling of 4RISE™ by Sino Biological represents a significant advancement in the wet-lab validation landscape. This service promises to expedite the research and development process, ultimately leading to innovative breakthroughs in biotechnology and pharmaceuticals. Explore the high-throughput wet-lab validation services provided by 4RISE™ today for rapid and robust scientific advancements!